APA (7th ed.) Citation

A, G., A, R., S, S., AR, B., G, v. K., SP, T., & JJ, C. (2025). Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: A pooled analysis. Blood advances, 9(18), 4705. https://doi.org/10.1182/bloodadvances.2025016536

Chicago Style (17th ed.) Citation

A, Guijosa, Ramirez-Gamero A, Sarosiek S, Branagan AR, von Keudell G, Treon SP, and Castillo JJ. "Ibrutinib Plus Rituximab Vs Ibrutinib Monotherapy in Patients with Waldenström Macroglobulinemia: A Pooled Analysis." Blood Advances 9, no. 18 (2025): 4705. https://doi.org/10.1182/bloodadvances.2025016536.

MLA (9th ed.) Citation

A, Guijosa, et al. "Ibrutinib Plus Rituximab Vs Ibrutinib Monotherapy in Patients with Waldenström Macroglobulinemia: A Pooled Analysis." Blood Advances, vol. 9, no. 18, 2025, p. 4705, https://doi.org/10.1182/bloodadvances.2025016536.